CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 53 enrolled
Drug / intervention
Experimental Product 1% Colloidal Oatmeal Balm +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02691507
NCT02691507Phase 2Completed
CompareCT.gov

A Clinical Trial to Determine the Therapeutic Benefit of an Investigational Over-The-Counter Cream on Dry, Itchy Skin of Adults and Children With Atopic Dermatitis.

Johnson & Johnson Consumer Inc. (J&JCI)·interventional·Posted Feb 25, 2016·Updated Mar 6, 2017

In Brief

A Phase 2 clinical trial evaluating EpiCeram Skin Barrier Emulsion and Experimental Product 1% Colloidal Oatmeal Balm for Atopic Dermatitis. Completed, enrolled 53 participants across 2 sites.

Detailed Summary

The objective of this 1 week trial is to evaluate the efficacy of an over-the-counter (OTC) 1% colloidal oatmeal skin protectant cream in adults and children with mild to moderate AD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 25, 2016
Enrollment StartFeb 1, 2016
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.4 years ago

Interventions

EpiCeram Skin Barrier Emulsiondevice

EpiCeram Skin Barrier Emulsion

Experimental Product 1% Colloidal Oatmeal Balmdrug

Experimental Product 1% Colloidal Oatmeal Balm